Surgery Partners, Inc. reports developments tied to its short-stay surgical facility network and outpatient delivery model. The company provides surgical and related ancillary care through ambulatory surgery centers, surgical hospitals, anesthesia services, multi-specialty physician practices and urgent care facilities, with revenue tied to patient care services and facility case activity.
Recurring SGRY news includes quarterly results, same-facility revenue and case trends, adjusted EBITDA and guidance, operational initiatives, portfolio optimization, acquisition activity, financing and leverage actions, share repurchase authorizations, board composition and shareholder communications involving the company’s strategic direction.
Surgery Partners, Inc. (NASDAQ:SGRY), a leading short-stay surgical facility owner and operator, has announced the release date for its third quarter 2024 financial results. The company will disclose its earnings before the market opens on Tuesday, November 12, 2024, followed by a conference call at 8:30 a.m. Eastern Time.
Investors and interested parties can access the live call by dialing 1-877-451-6152 (domestic) or 1-201-389-0879 (international). A replay will be available for two weeks after the call. Additionally, a simultaneous webcast of the conference call will be accessible through the Investor Relations section of the company's website at www.surgerypartners.com.
Surgery Partners, Inc. (NASDAQ:SGRY) reported strong Q2 2024 results, raising full-year guidance. Key highlights include:
- Revenues increased 14.2% to $762.1 million
- Same-facility revenues up 9.9%
- Adjusted EBITDA grew 18.1% to $118.3 million
- Adjusted EBITDA margin expanded 50 basis points to 15.5%
- Full-year guidance raised to >$3.075 billion revenue and >$508 million Adjusted EBITDA
The company deployed nearly $220 million on acquisitions and improved its balance sheet position. Cash and cash equivalents stood at $213.5 million, with $647.8 million available under its revolving credit facility. The total net debt to EBITDA ratio was approximately 3.8x at quarter-end.
Surgery Partners (NASDAQ:SGRY), a leading short-stay surgical facility operator, has announced the release date for its second quarter 2024 earnings report. The company will disclose its financial results before the market opens on Tuesday, August 6, 2024, followed by a conference call at 8:30 a.m. Eastern Time.
Investors can access the live call by dialing 1-800-579-2543 (domestic) or 1-785-424-1789 (international) with the Conference ID: SPI2Q24. A replay will be available for two weeks after the call. Additionally, a simultaneous webcast will be accessible through the Investor Relations section of the company's website at www.surgerypartners.com.
Surgery Partners, Inc. reported strong financial results for the first quarter of 2024, with revenues increasing by 7.7% to $717.4 million. The company's same-facility revenues grew by 10.2%, while the net loss was $12.4 million. Adjusted EBITDA reached $97.5 million, with an 8.2% growth compared to the previous year. The company raised its full-year 2024 guidance to at least $3.05 billion in revenue and at least $505 million in Adjusted EBITDA. Surgery Partners' executives highlighted strong growth driven by clinical quality, operational execution, and strategic acquisitions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.